Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Jeremy B Wingard,1 Darcie AP Delzell,2 Nathan V Houlihan,2 Jonathan Lin,2 Jon P Gieser1 1Wheaton Eye Clinic, Wheaton, IL 60187, USA; 2Mathematics and Computer Science Department, Wheaton College, Wheaton, IL, 60187, USACorrespondence: Jeremy B WingardWheaton Eye Clinic, 2015 N. Main Street, Wheaton,...
Enregistré dans:
Auteurs principaux: | Wingard JB, Delzell DAP, Houlihan NV, Lin J, Gieser JP |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bd57ea1c0f8344c38c7dfa48bd94ad6c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives
par: Modjtahedi BS, et autres
Publié: (2020) -
Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
par: Jacek Dziedziak, et autres
Publié: (2021) -
Management of neovascular age-related macular degeneration: Taiwan expert consensus
par: Ling Yeung, et autres
Publié: (2021) -
Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
par: Yannuzzi NA, et autres
Publié: (2019) -
Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration
par: Almeida DRP, et autres
Publié: (2021)